Research underlying Nobel prize in chemistry has sparked innovation and patent filings

​
December 2, 2025

Imagine a material that can capture water vapour from desert air during the night and then release water when the sun rises – this sounds like science fiction but has become a reality by the research made by Susumu Kitagawa, Richard Robson and Omar M. Yaghi, awarded the Nobel prize in Chemistry 2025.

This year’s laureates have created a new type of molecular entities, metal-organic frameworks, MOFs, with enormous potential. Besides water harvesting, future application areas include e.g. gas storage, water purification, carbon dioxide capture, and battery technology. The number of patent publications relating to MOFs has risen from close to zero in 2005 to near 4,000 in 2024.

MOFs – soon a term on everyone’s lips

Metal-organic frameworks, MOFs, are materials in which metal ions (or clusters) are connected by organic linkers to create a 3D network containing a vast number of well-defined cavities. The cavities can act as reservoirs for guest molecules that can enter and exit from the surrounding environment. The seemingly endless combinations of the building blocks (metal and linker) allow precise tailoring of MOF properties, such as cavity size and chemical functionality, to suit specific applications.

Source: © Johan Jarnestad/The Royal Swedish Academy of Sciences

MOFs are highly porous materials with exceptionally large internal surface areas. One gram of a MOF could have an internal surface area as big as a football field! This makes MOFs better adsorbents than previously known porous materials, such as zeolites or activated carbon.

MOFs are innovation drivers

The MOF technology has paved the way for a flood of innovations in various industrial sectors, such as e.g., chemical industry, healthcare & pharmaceuticals, energy, and environmental remediation.

The vast innovative activity is mirrored by the steep increase in patent filings in the MOF field. China shows the highest patent filing activity, followed by the US and South Korea. A large part of the patent application filings stem from universities, but also major companies like BASF and ExxonMobile can be found among the top filers.

Credit: CAS Content Collection (Michael McCoy Chemical & Engineering News, May27, 2025: “Eye on Patents: Powering EVs and capturing CO2 with metal-organic frameworks”)

Laureates are patent-conscious

Considering the steep rise of patent applications relating to MOFs, it is evident that this field attracts a lot of interest, both in academia and industry. The Nobel laureates themselves also have their research work protected by several patents.

Omar M. Yaghi (together with fellow inventors) has a patent relating to a moisture harvester containing a MOF as water capturing material. This allows liquid water to be collected, also from dry air, e.g. in desert environments. The collected water is suitable for human consumption and can also be used for irrigation of crops. It is easy to envision the impact this invention may have for populations in areas where water supply is scarce.

(Figure 1 from EP 3837399 B1 – representative patent family member)

Susumu Kitagawa (and fellow inventors) holds a patent relating to a method for separating and storing highly unstable per- and polyfluoroalkyl substances (PFAS), such as tetrafluorethylene, through adsorption to a MOF. PFAS are widely used industrially, and the possibility to separate, store and transport these toxic and hazardous molecules in a safe way is of great value for humans and the environment.

(Figure 9 from EP 3339281 B1 – representative patent family member)

The future is bright

The MOF science is still new, and the broad use and application of MOFs in an industrial scale are yet to be explored. In times of climate change and sustainability challenges, they at least bring a fair amount of hope and expectations to the table.  

The scientific community is excited that the basic research behind MOFs is being awarded the Nobel prize, and Susumu Kitagawa, Richard Robson and Omar M. Yaghi have surely inspired to continued ground-breaking research and innovation. Who would not want to join the solemn Nobel prize ceremony and dinner in beautiful Stockholm?

‍

The Latest Thought Leadership pieces in the Content Hub

The people, physics and patents of the 2025 Nobel prize
December 9, 2025
The 2025 Nobel Prize in Physics recognised John Clarke, Michel H. Devoret, and John M. Martinis for proving macroscopic quantum tunnelling in electric circuits, a breakthrough that enabled quantum computing. Their pioneering research led to hundreds of patents, including innovations in MRI and quantum technology, highlighting the real-world impact of their discoveries.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
Is Your AI Conversation Privileged?
08 May 2026
Recent US court decisions have, for the first time, tested whether conversations with AI tools can be protected by legal privilege. In United States v. Heppner, a court held that documents generated by a defendant using a public AI platform were not protected by attorney‑client privilege, largely because the AI was not used within a lawyer‑directed relationship and the platform’s terms allowed data retention and disclosure. By contrast, in Warner v. Gilbarco, another court found that AI‑assisted materials created by a self‑represented litigant were protected under the work‑product doctrine, which has a more forgiving standard for waiver.
The evolution of nucleic acid sequencing and what it means for Genomics and IP
27 April 2026
This article outlines the evolution of nucleic acid sequencing, from early Sanger methods to next‑generation and long‑read technologies. The journey from deciphering individual DNA strands to sequencing entire genomes in hours represents one of biotechnology's most impressive transformations. The first human genome, completed through the Human Genome Project, took around 13 years to sequence and cost billions of dollars, whereas modern sequencing methods can now deliver a genome in hours for a few hundred dollars. For those interested in patents and life sciences, understanding the technical evolution of sequencing methods offers insights into how fundamental scientific advances translate into valuable patent portfolios.
World IP Day: The big ideas shaping IP's fastest-moving fields
24 April 2026
For World IP Day, we asked experts of EIP’s five growth areas: Uniphy, Ampliphy, Stratiphy, Codiphy and Quantiphy, to share a quick insight on innovation, IP trends, and what excites them about the future. Each responded to a single, focused question reflecting the role their team plays across EIP.
Meet the EIP team heading to INTA 2026 in London
23 April 2026
INTA's Annual Meeting is coming to London. From 2–6 May 2026, the ExCeL will host more than 10,000 trade mark and IP professionals from over 100 jurisdictions — five days of sessions, side events, and the kind of corridor conversations that turn into lasting working relationships.
National offices report increases in national patent applications throughout Europe: Is the EPO no longer “killing” the national offices?
27 March 2026
National patent offices across Europe have reported a marked increase in patent filings in 2025, breaking with a long‑standing downward trend. Data from Germany, France, Italy, Sweden, Austria, Spain and Norway point to growing activity driven by digital technologies, electrification and increased university participation. At the same time, offices report a rise in self‑drafted and AI‑assisted applications, which may lower barriers to entry but also raise concerns about application quality and examination efficiency.
Make your bio(pharma) IP investment ready
22 March 2026
This recap of our LinkedIn Live series focuses on helping (bio)pharma businesses make their IP investment‑ready. Across three sessions, experts will discuss building resilient IP portfolios, making strategic IP decisions ahead of funding rounds, and what the evolving 2026 (bio)pharma landscape means for long‑term IP strategy.
Are professional guidelines making Patent Attorneys too cautious on AI?
19 February 2026
As AI use accelerates in patent practice, many European patent attorneys remain cautious due to professional AI guidelines from the epi. This article argues those guidelines are not a barrier, but a baseline for responsible use.
Beyond CRISPR: Precision to Platform
23 January 2026
Gene editing is entering a new phase, moving beyond CRISPR-Cas9’s breakthrough but costly, bespoke therapies toward more precise and scalable platforms. While CRISPR-based treatments like Casgevy have proven clinical success, they remain expensive and entangled in ongoing patent disputes over foundational IP. Next-generation tools such as base editing and prime editing avoid double-strand DNA breaks, enabling more accurate corrections and broader therapeutic potential. The field’s focus is now shifting to disease-agnostic platforms that can be adapted across many conditions, improving access and efficiency.